Garcinia xanthones as orally active antitumor agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Xanthones are a class of natural products with diverse biological activities.
• Gambogic acid, a prominent xanthone, exhibits potent antitumor properties but faces challenges in clinical application.
• Developing novel xanthone analogs with improved efficacy and drug-like properties is crucial for cancer therapy.

Purpose of the Study:

• To design and synthesize a library of structurally diverse, natural product-like xanthones based on the gambogic acid scaffold.
• To evaluate the in vitro antitumor activity and key physicochemical properties of the synthesized compounds.
• To identify promising candidates for further in vivo investigation and potential therapeutic development.

Main Methods:

• A novel synthetic strategy involving regioselective propargylation of hydroxyxanthone substrates was employed.
• 99 structurally diverse xanthone analogs were synthesized.
• In vitro antitumor activity was assessed, and physicochemical properties (log D7.4, aqueous solubility, permeability) were determined for 40 compounds.
• In vivo efficacy studies were conducted for selected compounds.

Main Results:

• A library of 99 novel xanthones was successfully synthesized.
• Significant in vitro antitumor activity was observed across the synthesized compounds.
• Compound 112 exhibited potent in vivo oral antitumor activity, surpassing that of gambogic acid.
• Physicochemical properties were evaluated to correlate structure with activity and drug-likeness.

Conclusions:

• The developed synthetic strategy enables the creation of diverse xanthone analogs.
• Compound 112 represents a promising candidate for further development as an orally administered antitumor agent.
• This study provides valuable insights into the structure-activity relationships of xanthone-based anticancer compounds.